Krsnaa Diagnostics Ltd. News and Updates

Name: Latest research reports of Krsnaa Diagnostics Ltd. authored by invest4Edu and published by - Trendlyne research reports.
Item: Krsnaa Diagnostics Ltd.
Rating: 5
Author: invest4Edu

Keep track of all breaking news on Krsnaa Diagnostics Ltd. from all sources in a single place.

Krsnaa Diagnostics Ltd.

10 Nov 2025

806.10

1.25%

to see Rapid results content

Krsnaa Diagnostics Ltd.

01 Sep 2025

806.10

1.25%

Q1FY26 Result Update

Buy: Krsnaa Diagnostics Ltd.

invest4Edu

In Q1FY26, Krsnaa Diagnostics (Krsnaa) reported revenue of ?193 crores, up 13.4% YoY. EBITDA improved 20.5% YoY to ?51.4 crores, resulting in a margin expansion to 26.6% in Q1FY26 vs. 25.1% in Q1FY25, showing efficiency, cost controls, and disciplined execution across PPP and retail units.

Krsnaa Diagnostics Ltd. is trading below its 50 day SMA of 807.0

Krsnaa Diagnostics Ltd.

12 Aug 2025

806.10

1.25%

Krsnaa Diagnostics Results Earnings Call for Q1FY26

Conference Call with Krsnaa Diagnostics Management and Analysts on Q1FY26 Performance and Outlook. Listen to the full earnings transcript.

audio

Krsnaa Diagnostics Ltd.

12 Aug 2025

806.10

1.25%

to see Rapid results content

Krsnaa Diagnostics Ltd.

08 Jul 2025

806.10

1.25%

Krsnaa Diagnostics rises 6% in trade; what's driving investor interest?

Business Standard

Krsnaa Diagnostics share price rose 6 per cent in trade, logging an intraday high at 789.1 per share; here's why

Krsnaa Diagnostics Ltd. has gained 25.68% in the last 6 Months

Krsnaa Diagnostics Ltd.

14 May 2025

806.10

1.25%

Krsnaa Diagnostics Q4 Results Review: Systematix Maintains 'Buy', Revises Target Price - Here's Why

NDTV Profit

Receivables collection challenges impact Krsnaa's growth, adds Systematix.

Krsnaa Diagnostics Ltd. is trading above its 200 day SMA of 771.8

Krsnaa Diagnostics Ltd.

13 May 2025

806.10

1.25%

to see Rapid results content

Krsnaa Diagnostics Ltd.

19 Feb 2025

806.10

1.25%

Maintaining a positive outlook whilst addressing short-term headwinds

Buy: Krsnaa Diagnostics Ltd.

Recommendation Target

Khambatta Securities

Krsnaa Diagnostics Limited’s (KDL’s) revenue decreased due to seasonal
factors and temporary operational issues. The Mumbai BMC project ended
earlier than expected, and the Maharashtra city and Madhya Pradesh MRI
installations experienced delays due to site handover issues which led to a
temporary dip in revenues.